7.55
Schlusskurs vom Vortag:
$7.56
Offen:
$7.52
24-Stunden-Volumen:
95,319
Relative Volume:
0.64
Marktkapitalisierung:
$157.75M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-22.38M
KGV:
-5.3546
EPS:
-1.41
Netto-Cashflow:
$-15.54M
1W Leistung:
-3.94%
1M Leistung:
+0.00%
6M Leistung:
+12.02%
1J Leistung:
+16.15%
Nuvectis Pharma Inc Stock (NVCT) Company Profile
Firmenname
Nuvectis Pharma Inc
Sektor
Branche
Telefon
360-837-7232
Adresse
1 BRIDGE PLAZA, SUITE 275, FORT LEE
Vergleichen Sie NVCT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
NVCT
Nuvectis Pharma Inc
|
7.55 | 157.95M | 0 | -22.38M | -15.54M | -1.41 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
598.89 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
299.94 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvectis Pharma Inc Stock (NVCT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-02 | Eingeleitet | Maxim Group | Buy |
2025-03-17 | Eingeleitet | Laidlaw | Buy |
2022-07-13 | Eingeleitet | Ladenburg Thalmann | Buy |
Nuvectis Pharma Inc Aktie (NVCT) Neueste Nachrichten
Real time scanner hits for Nuvectis Pharma Inc. explainedFree Quick Gain Stock Watch With Indicators - Newser
Exit strategy if you’re trapped in Nuvectis Pharma Inc.Asset Safety Selection Using Quantitative Analysis - Newser
Is Nuvectis Pharma Inc. a growth stock or a value stockExpert Picks Review With Low Risk - jammulinksnews.com
Will Nuvectis Pharma Inc. benefit from macro trendsFree Fundamental Winners With Safe Entry Plan - Newser
How to read the order book for Nuvectis Pharma Inc.Momentum Detection with Entry Optimization - Newser
Volume spikes in Nuvectis Pharma Inc. stock – what they meanControlled Entry Strategy With Safety Analytics - Newser
Using R and stats models for Nuvectis Pharma Inc. forecastingExpert-Backed High Yield Stock Watchlist - Newser
Why Nuvectis Pharma Inc. stock attracts strong analyst attentionOversold Recovery Opportunity Stocks Attract Buyers - metal.it
Key resistance and support levels for Nuvectis Pharma Inc.Real-Time AI Sentiment and Price Forecast - Newser
Nuvectis Pharma Inc. Volume Confirms Breakout — Analysts BullishTrade Setups With Clear Risk Limits Highlighted - metal.it
Published on: 2025-07-29 06:16:31 - Newser
What makes Nuvectis Pharma Inc. stock price move sharplyFree Trend Analysis for Safer Trades - Newser
How strong is Nuvectis Pharma Inc. company’s balance sheetStock Market Picks With High Returns - jammulinksnews.com
Why is Nuvectis Pharma Inc. stock attracting strong analyst attentionMarket-beating performance - jammulinksnews.com
Is it time to cut losses on Nuvectis Pharma Inc.Volatility Analysis and Entry Risk Mapping - Newser
Exit strategy if you’re trapped in Nuvectis Pharma Inc. Stable Profit Zone and Loss Control Analysis - Newser
Real time scanner hits for Nuvectis Pharma Inc. explained Top Stock Picks with Forecast Accuracy - Newser
What institutional investors are buying Nuvectis Pharma Inc. stockEarnings Report Ideas With High Returns - jammulinksnews.com
Does Nuvectis Pharma Inc. stock perform well during market downturnsGrow your portfolio with growth-oriented stocks - jammulinksnews.com
What is Nuvectis Pharma Inc. company’s growth strategyCapitalize on market trends with confidence - jammulinksnews.com
What is the dividend policy of Nuvectis Pharma Inc. stockExplosive earnings growth - jammulinksnews.com
When is Nuvectis Pharma Inc. stock expected to show significant growthPowerful market insights - jammulinksnews.com
Nuvectis Pharma Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingChart Breakout Alert - Newser
Why Nuvectis Pharma Inc. stock is on top investor watchlistsSkyrocketing investment returns - jammulinksnews.com
Nuvectis Pharma Inc. Stock Analysis and ForecastSuperior returns - Autocar Professional
What drives Nuvectis Pharma Inc. stock priceRecord-breaking capital gains - Autocar Professional
What analysts say about Nuvectis Pharma Inc. stockUnstoppable profit momentum - PrintWeekIndia
Is Nuvectis Pharma Inc. a good long term investmentTremendous wealth creation - jammulinksnews.com
(NVCT) On The My Stocks Page - news.stocktradersdaily.com
Finanzdaten der Nuvectis Pharma Inc-Aktie (NVCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):